Oppenheimer analyst Kristen Owen raised the firm’s price target on Nutrien (NTR) to $78 from $76 and keeps an Outperform rating on the shares. While results were light, progress made on portfolio actions continue to drive the Nutrien thesis, the firm says. Oppenheimer sees a catalyst-rich year ahead for Nutrien, with farmer fundamentals stabilizing, and decisions for its Phosphate business, Trinidad nitrogen, and Brazil Retail all expected to improve earnings stability and strengthen free cash flow generation.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTR:
- Nutrien price target raised to $74 from $60 at Jefferies
- Nutrien price target raised to $80 from $75 at RBC Capital
- Nutrien Earnings Call Highlights Costs, Volumes, Buybacks
- Nutrien Sets Record Date and Details for Virtual 2026 Annual Meeting
- Nutrien price target raised to $81 from $80 at TD Securities